467 related articles for article (PubMed ID: 17786403)
1. [The physician caught between two chairs. Comments on the difficulty in dealing with off-label use].
Harder Yv
Urologe A; 2007 Oct; 46(10):1429-34. PubMed ID: 17786403
[No Abstract] [Full Text] [Related]
2. [The rheumatologist's conflict between "off-label" prescription and failure to render assistance].
Hellmich B; Gross WL
Z Rheumatol; 2003 Feb; 62(1):34-5. PubMed ID: 12624800
[No Abstract] [Full Text] [Related]
3. [A shock for 348 colleagues. Penalties up to 400,000 euro].
Schmidt K
MMW Fortschr Med; 2005 Jun; 147(22):40-2. PubMed ID: 15977633
[No Abstract] [Full Text] [Related]
4. [Does red-green destroy phytotherapy?].
Krankenpfl J; 2003; 41(4-6):111. PubMed ID: 12929322
[No Abstract] [Full Text] [Related]
5. [Off-label use of drugs--the legal framework].
Koyuncu A
Dtsch Med Wochenschr; 2012 Jul; 137(30):1519-23. PubMed ID: 22869512
[No Abstract] [Full Text] [Related]
6. [New drugs must henceforth be better than the current standard. What remains for physician therapy autonomy?].
Schmidt K
MMW Fortschr Med; 2006 Dec; 148(49-50):61, 63. PubMed ID: 17619334
[No Abstract] [Full Text] [Related]
7. Health insurance oversight issue brief: mandated benefits: off-label drug coverage requirements: year end report--2004.
Plaza CI
Issue Brief Health Policy Track Serv; 2004 Dec; ():1-9. PubMed ID: 15726733
[No Abstract] [Full Text] [Related]
8. Finance issue brief: mandated benefits: off-label drug coverage requirements: year end report-2003.
Plaza CI
Issue Brief Health Policy Track Serv; 2003 Dec; ():1-9. PubMed ID: 14870745
[No Abstract] [Full Text] [Related]
9. [Legal decisions of german supreme courts about prescription of drugs for not registered indications ("off-label-use")].
Wetterling T
Fortschr Neurol Psychiatr; 2004 May; 72(5):255-9. PubMed ID: 15136946
[TBL] [Abstract][Full Text] [Related]
10. [Solutions for off-label therapy].
Schmidt WA
Z Rheumatol; 2003; 62(Suppl 2):II54-6. PubMed ID: 14648094
[TBL] [Abstract][Full Text] [Related]
11. [Authorization and reimbursement of orphan drugs in an international comparison].
Roll K; Stargardt T; Schreyögg J
Gesundheitswesen; 2011 Aug; 73(8-9):504-14. PubMed ID: 20848380
[TBL] [Abstract][Full Text] [Related]
12. [Off-label use in psychopharmacotherapy. Letter to Federal Minister Ulla Schmidt, Pulheim, 22 January 2003].
Fritze J
Nervenarzt; 2003 Apr; 74(4):389; discussion 390. PubMed ID: 12800838
[No Abstract] [Full Text] [Related]
13. [Thorough clarification of national health insurance statistics. This prevents regress actions].
Thomas A
MMW Fortschr Med; 2007 Nov; 149(48):56-7. PubMed ID: 18163264
[No Abstract] [Full Text] [Related]
14. Prescription drug costs easier to swallow.
State Legis; 2010 Apr; 36(4):10. PubMed ID: 20397320
[No Abstract] [Full Text] [Related]
15. [Off-label use in oncology: an inexhaustible topic?!].
Weissbach L; Riese J
Urologe A; 2006 Nov; 45(11):1410, 1412-4. PubMed ID: 17043888
[TBL] [Abstract][Full Text] [Related]
16. [Open letter to minister of health. Toad medicine].
Erdmann E
Krankenpfl J; 2003; 41(4-6):110-1. PubMed ID: 12929321
[No Abstract] [Full Text] [Related]
17. [Leflunomide and TNF inhibitors. Experiences from precription recourse proceedings].
Brandt-Jürgens J
Z Rheumatol; 2013 Mar; 72(2):114-6. PubMed ID: 23223912
[No Abstract] [Full Text] [Related]
18. [Is the physician the insurance broker for his patients?].
Wienke A; Sailer R
Laryngorhinootologie; 2013 Dec; 92(12):834-5. PubMed ID: 24285207
[No Abstract] [Full Text] [Related]
19. [Regulation for improving economics in drug treatment].
Holstein L; Koch B
Chirurg; 2006 Jul; Suppl():214-6. PubMed ID: 17855869
[No Abstract] [Full Text] [Related]
20. [Can physicians really save still more in drug prescriptions?].
Schmidt K
MMW Fortschr Med; 2006 Feb; 148(5):44-5. PubMed ID: 16518938
[No Abstract] [Full Text] [Related]
[Next] [New Search]
